TRAW

MKT CAP:$22M

Traws Pharma Inc

Market Cap

$22M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.37+$0.04 (+3.01%)

Jun 5, 2026

52W High $3.1352W Low $1.09

Company Details

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are desi...

CEO

—

IPO Date

Jan 2, 2001

Website

www.trawspharma.com

Key Metrics TTM

Revenue

$3M

+1129.1% YoY

Net Income

-$19M

EPS (Diluted)

Free Cash Flow

-$2.6B

Revenue / Share

$0.26

Gross Margin

100.0%

Operating Margin

-703.2%

Net Margin

-663.1%

FCF Margin

-92786.7%

P/S

8.0x

P/E

Earnings Reports

Q1 2026

May 15, 2026

$57.0K+0.0%

FY 2025

Dec 31, 2025

$3M+1134.5%

Q4 2025

Dec 31, 2025

$0-100.0%

Q3 2025

Nov 13, 2025

$0-100.0%

Q2 2025

Aug 14, 2025

$3M+4780.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee